Pfizer expects adjusted per-share earnings of $2.80 to $3 next year, below analysts’ consensus estimate of $3.06, according to FactSet. Revenue is expected to total $59.5 billion to $62.5 billion, ...

The company reiterated its 2025 adjusted earnings guidance of $3 to $3.15 a share. It guided for 2025 revenue of $62 billion, compared with its previous forecast of $61 billion to $64 billion.

Pfizer last month closed its up to $10bn (€8.5bn) acquisition of Metsera after winning shareholder approval, gaining a ...

Winter is here, and it is the season to enjoy all good food, but in our love for gluttony and overindulgence, we often ignore ...

FDA Commissioner Marty Makary defends agency leadership in NPR interview; New long COVID-19 research links disease to chronic ...

Covid-19 vaccination during pregnancy sharply reduces the risk of severe illness, hospitalisation and preterm birth, a major ...

Pregnant people who received a COVID-19 vaccine were far less likely to experience severe illness or deliver their babies prematurely, according to a major new UBC-led study published in JAMA.

The U.S. Food and Drug Administration (FDA) is considering adding the strongest safety warning available to COVID-19 vaccines ...

Dr. Deborah Money, senior author of the paper published Monday in JAMA, said having such a large study "robustly" confirms ...

FDA Commissioner Martin Makary discusses vaccine policy, COVID-era decisions and the erosion of trust in government health ...

A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after COVID-19 mRNA vaccination, ...

FDA decides against black box warning for Covid vaccines despite ongoing safety reviews, focusing on myocarditis concerns.